These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3091882)

  • 21. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Metastatic breast cancer: controlled trial of chemotherapy with and without hormones].
    Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Magdelenat H; Asselain B; Pouillart P
    Bull Cancer; 1984; 71(5):432-41. PubMed ID: 6395920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].
    Schjølseth SA; Hagen T; Ottestad L; Jakobsen E
    Tidsskr Nor Laegeforen; 1995 Nov; 115(27):3371-3. PubMed ID: 7491579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitomycin and tamoxifen versus mitolactol, doxorubicin, and tamoxifen in patients with previously treated breast cancer.
    Falkson G; Gelman RS; Tormey DC; Taylor SG; Falkson HC
    Cancer Treat Rep; 1985; 69(7-8):755-60. PubMed ID: 4016786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for breast carcinoma: a well tolerated adjuvant regimen.
    Isaac N; Panzarella T; Lau A; Mayers C; Kirkbride P; Tannock IF; Vallis KA
    Cancer; 2002 Aug; 95(4):696-703. PubMed ID: 12209711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Controlled study of MQF-OK therapy with FT and with UFT on various advanced gastrointestinal cancers. Hirosaki Cooperative Study Group of Cancer Chemotherapy].
    Sakata Y; Munakata A; Baba T; Saitoh S; Itoh T; Tamura Y; Furukohori N; Suzuki H; Kimura T; Kawata K
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2065-71. PubMed ID: 3134859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-tegafur combination therapy with or without levamisole. 1].
    Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Toda T; Furusawa M; Koga S; Hashimoto I; Kondo T; Fujimoto S; Sugiyama Y; Abe O; Ohya M
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2133-47. PubMed ID: 6820890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Long-term results of preoperative chemotherapy for operable breast cancer].
    Zhang B; Cai Y; Zhang Q
    Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):277-80. PubMed ID: 11038758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of metastatic colorectal carcinoma with 5-FU, mitomycin, vincristine, and methotrexate.
    Beck TM; Curtis PW; Woodard DA; Hart NE; Smith CE
    Cancer Treat Rep; 1984 Apr; 68(4):647-50. PubMed ID: 6424937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Regional therapy breast cancer liver metastases].
    Lorenz M; Wiesner J; Staib-Sebler E; Encke A
    Zentralbl Chir; 1995; 120(10):786-90. PubMed ID: 7502593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.
    Keane MM; Ettenberg SA; Nau MM; Russell EK; Lipkowitz S
    Cancer Res; 1999 Feb; 59(3):734-41. PubMed ID: 9973225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The present status in prophylaxis and treatment of HIV infected patients with hemophilia in Japan].
    Mori K; Sakai H; Suzuki S; Akutsu Y; Ishikawa M; Aihara M; Yokoyama M; Sato Y; Okaniwa S; Endo Y
    Rinsho Byori; 1989 Nov; 37(11):1200-8. PubMed ID: 2689699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of the effects of thymopentin on the incidence of leucopenia in patients treated with chemotherapy for breast carcinoma].
    Cartia GL
    Minerva Med; 1990 Nov; 81(11):815-7. PubMed ID: 2255416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The frequency of patients with positive HIV-antibody in the various groups and the prognosis of these patients treated with SNMC].
    Endo Y; Mamiya S; Iwamoto K; Niitsu H; Itoh T; Miura A
    Rinsho Byori; 1990 Feb; 38(2):188-92. PubMed ID: 2329721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of glycyrrhizin (SNMC: Stronger Neo-Minophagen C) in hemophilia patients with HIV-1 infection.
    Mori K; Sakai H; Suzuki S; Akutsu Y; Ishikawa M; Imaizumi M; Tada K; Aihara M; Sawada Y; Yokoyama M
    Tohoku J Exp Med; 1990 Oct; 162(2):183-93. PubMed ID: 2129071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of glycyrrhizin in children with liver dysfunction associated with cytomegalovirus infection.
    Numazaki K; Umetsu M; Chiba S
    Tohoku J Exp Med; 1994 Feb; 172(2):147-53. PubMed ID: 8073426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myelosuppression after methotrexate, mitozantrone, and mitomycin C for treatment of advanced breast cancer.
    Marks A; Goodman A; Dougherty S; Ashford R
    Lancet; 1987 Apr; 1(8538):915. PubMed ID: 2882308
    [No Abstract]   [Full Text] [Related]  

  • 38. Unexpected prolonged myelosuppression after mitomycin, mitoxantrone and methotrexate.
    Muhonen TT; Wiklund TA; Blomqvist CP; Pyrhönen SO
    Eur J Cancer; 1992; 28A(12):1974-6. PubMed ID: 1419293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The suppressive effect of glycyrrhizin on TSH secretion (author's transl)].
    Matsui J; Ariga Y; Nakajima K; Kudo S; Mizuno K
    Horumon To Rinsho; 1980 Jan; 28(1):57-61. PubMed ID: 7371207
    [No Abstract]   [Full Text] [Related]  

  • 40. Myelotoxicity of methotrexate, mitozantrone, and mitomycin C.
    Morton AR; Anderson H; Howell A
    Lancet; 1987 Jun; 1(8548):1494. PubMed ID: 2885486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.